A review of exenatide as adjunctive therapy in patients with type 2 diabetes

BACKGROUND: Incretin glucagon-like peptide-1 (GLP-1) is a hormone released from cells in the gastrointestinal tract (GI), leading to glucose-dependent insulin release from the pancreas. It also suppresses postprandial hyperglycemia, glucagon secretion and slows gastric emptying. Exenatide (EXE), a f...

Descripción completa

Detalles Bibliográficos
Autores principales: Robles, Gisela I, Singh-Franco, Devada
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769236/
https://www.ncbi.nlm.nih.gov/pubmed/19920937

Ejemplares similares

Ejemplares similares